These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36123161)

  • 1. Efficacy of 0.01% Atropine Eye Drops in Controlling Myopia Progression and Axial Elongation in Children: A Meta-analysis Based on Randomized Controlled Trials.
    Sun W; Hasebe S
    Acta Med Okayama; 2022 Aug; 76(4):457-463. PubMed ID: 36123161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
    Repka MX; Weise KK; Chandler DL; Wu R; Melia BM; Manny RE; Kehler LAF; Jordan CO; Raghuram A; Summers AI; Lee KA; Petersen DB; Erzurum SA; Pang Y; Lenhart PD; Ticho BH; Beck RW; Kraker RT; Holmes JM; Cotter SA;
    JAMA Ophthalmol; 2023 Aug; 141(8):756-765. PubMed ID: 37440213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety.
    Hansen NC; Hvid-Hansen A; Møller F; Bek T; Larsen DA; Jacobsen N; Kessel L
    BMC Ophthalmol; 2023 Oct; 23(1):438. PubMed ID: 37904082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal Contact Lenses and 0.01% Atropine Eye Drops for Myopia Control Study: Research Protocol for a 1-Year, Randomized, Four-Arm, Clinical Trial in Schoolchildren.
    Hiraoka T; Kiuchi G; Hiraoka R; Maruo K; Oshika T
    Eye Contact Lens; 2023 Apr; 49(4):172-177. PubMed ID: 36848188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children - a prospective, randomized, double-masked, and crossover trial.
    Wang W; Zhang F; Yu S; Ma N; Huang C; Wang M; Wei L; Zhang J; Fu A
    Eur J Pediatr; 2023 Jun; 182(6):2597-2606. PubMed ID: 36944782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose AtropIne for Myopia Control in Children (AIM): protocol for a randomised, controlled, double-blind, multicentre, clinical trial with two parallel arms.
    Farassat N; Böhringer D; Küchlin S; Molnár FE; Schwietering A; Seger D; Hug MJ; Knöbel AB; Schneider-Fuchs S; Ihorst G; Wabbels B; Beisse C; Ziemssen F; Schuettauf F; Hedergott A; Ring-Mangold T; Schuart C; Wolf A; Schmickler S; Biermann J; Eberwein P; Hufendiek K; Eckstein A; Gusek-Schneider G; Schittkowski M; Lischka T; Lagrèze WA
    BMJ Open; 2023 Apr; 13(4):e068822. PubMed ID: 37080623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy Comparison of Repeated Low-Level Red Light and Low-Dose Atropine for Myopia Control: A Randomized Controlled Trial.
    Chen Y; Xiong R; Chen X; Zhang J; Bulloch G; Lin X; Wu X; Li J
    Transl Vis Sci Technol; 2022 Oct; 11(10):33. PubMed ID: 36269184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of myopic rebound effect after discontinuation of treatment with 0.01% atropine eye drops in Japanese school-age children.
    Hieda O; Hiraoka T; Fujikado T; Ishiko S; Hasebe S; Torii H; Takahashi H; Tanaka S; Kinoshita S;
    Jpn J Ophthalmol; 2023 Sep; 67(5):602-611. PubMed ID: 37548816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Atropine 0.01% Eye Drops on the Difference in Refraction and Axial Length between Right and Left Eyes.
    Liang X; Wei S; Li SM; An W; Du J; Sun Y; Gan J; Bai W; Cai Z; Song Q; Yin L; Wang N
    Ophthalmic Res; 2023; 66(1):496-505. PubMed ID: 36603556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression.
    Pérez-Flores I; Macías-Murelaga B; ; Barrio-Barrio J
    Sci Rep; 2023 Sep; 13(1):16310. PubMed ID: 37770602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of atropine in myopic children: A meta-analysis of randomized controlled trials.
    Long H; Shi MH; Li X
    J Fr Ophtalmol; 2023 Oct; 46(8):929-940. PubMed ID: 37147148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Dose Atropine in Preventing the Progression of Childhood Myopia: A Randomised Controlled Trial.
    Sharma I; Das GK; Rohatgi J; Sahu PK; Chhabra P; Bhatia R
    Curr Eye Res; 2023 Apr; 48(4):402-407. PubMed ID: 36576170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myopia progression after cessation of low-dose atropine eyedrops treatment: A two-year randomized, double-masked, placebo-controlled, cross-over trial.
    Wei S; Li SM; An W; Du J; Liang X; Sun Y; Gan J; Bai W; Tian J; Cai Z; Yin L; Wang N
    Acta Ophthalmol; 2023 Mar; 101(2):e177-e184. PubMed ID: 35999653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose atropine 0.01% for the treatment of childhood myopia: a pan-India multicentric retrospective study.
    Saxena R; Gupta V; Dhiman R; Joseph E; Agarkar S; Neena R; Magdalene D; Jethani J; Ganesh SC; Patil M; Gogri P; Gadaginamath S; Sen P; Sukhija J; Mishra D; Matalia JH; Sahu A; Kapoor S; Nishanth S; Chaurasia S; Pawar N; Deori N; Sivaraman V; Bordoloi A; Tibrewal S; Singh D; Prasad P; Phuljhele S; Sharma N
    Br J Ophthalmol; 2024 Mar; 108(4):588-592. PubMed ID: 38290805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the reports of low-concentration atropine in controlling myopia in children.
    Zhang M; Qiu W; An M; Sun Y; Zhang Z; Yu C
    J Fr Ophtalmol; 2023 Mar; 46(3):239-248. PubMed ID: 36797093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for a parallel assignment prospective, randomised, double-blinded, placebo-controlled trial to evaluate the efficacy of 0.01% atropine for near work-induced transient myopia and myopic progression in China.
    Qin G; Chen J; Hu L; Qi Y; Xu L; He W; Yu S; Pazo EE; He X
    BMJ Open; 2023 Dec; 13(12):e079833. PubMed ID: 38128934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myopia outcome study of atropine in children: Two-year result of daily 0.01% atropine in a European population.
    Loughman J; Kobia-Acquah E; Lingham G; Butler J; Loskutova E; Mackey DA; Lee SSY; Flitcroft DI
    Acta Ophthalmol; 2024 May; 102(3):e245-e256. PubMed ID: 37694816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Atropine in the Control of Myopia.
    Tan D; Tay SA; Loh KL; Chia A
    Asia Pac J Ophthalmol (Phila); 2016; 5(6):424-428. PubMed ID: 27898446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials.
    Kumari S; Anand R; Tripathi S; Mishra RC; Jha SK
    J Family Med Prim Care; 2022 Nov; 11(11):6668-6677. PubMed ID: 36993096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myopia prevention and control in children: a systematic review and network meta-analysis.
    Zhang G; Jiang J; Qu C
    Eye (Lond); 2023 Nov; 37(16):3461-3469. PubMed ID: 37106147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.